Search Results
Customized Prostate Cancer Risk Screening Using Novel Nomograms With MRI
Predicting 177Lu-PSMA-617 in men with prostate cancer with nomograms
Case Study #3: Applying a Clinical Genomic Nomogram to the ADT Decision in 46 y.o. w/ Gleason 4+3=7
Case Study #1: Applying a Clinical Genomic Nomogram to the ADT Decision in High Volume Gleason 3+4=7
Applying a Clinical Genomic Nomogram for ADT Decisions in Intermediate Risk Prostate Cancer
Prostate Health: Risk Detection and Optimizing Personalized Treatment
Novel Tools In The Active Surveillance For Prostate Cancer_compress
Prostate Cancer Screening - M. Bjurlin and M. Crabtree - 20190508
Evolving Role of MRI and Genomics in Active Surveillance for Prostate Cancer
Part 7 -Nomograms Predicting Overall Survival in Locally Advanced Cervical Cancer treated - Dr Aditi
Incorporating Genomic Testing for Prostate Cancer into Your Practice Webcast (2022)
Tests, imaging and biomarkers to diagnose or monitor prostate cancer
